Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

There was no significant difference in vitamin D levels between the two groups.Characteristics of the subjects according to MAFLDTotal subjects (n = 852)MAFLDp-valueAUROC (95% CI)No (n = 574)Yes (n = 278)Sex < 0.0001 Male300 (52.3)209 (75.2) Female274 (47.7)69 (24.8)Alcohol consumption0.147 N360 (62.7)160 (57.6) Y214 (37.3)118 (42.4)Smoking < 0.0001 N446 (77.7)184 (66.2) Y128 (22.3)94 (33.8)FLI < 0.0001 30 < 407 (89.8)80 (43.0) ≥ 6046 (10.2)106 (57.0)Age (years)52.44 ± 10.2052.97 ± 9.310.462BMI23.63 ± 2.8426.64 ± 3.12 < 0.0001SBP (mmHg)121.19 ± 12.59126.15 ± 11.77 < 0.0001DBP (mmHg)74.63 ± 9.5678.84 ± 10.02 < 0.0001WC (cm)82.34 ± 8.0789.23 ± 9.17 < 0.0001FBS (mg/dL)92.3 ± 23.3899.93 ± 26.27 < 0.0001TG (mg/dL)98.8 ± 64.16150.91 ± 143.04 < 0.0001HDL-C (mg/dL)56.74 ± 12.952.4 ± 13.72 < 0.0001LDL-C (mg/dL)119.53 ± 32.72124.16 ± 38.030.082AST (IU/L)30.82 ± 21.9437.66 ± 38.420.001ALT (IU/L)27.52 ± 24.3240.15 ± 29.71 < 0.00010.701 (0.657 to 0.745)GGT (IU/L)36.76 ± 66.8672.79 ± 215.350.0070.668 (0.622 to 0.714)Uric acid/creatinine6.29 ± 1.756.61 ± 1.560.011hs-CRP (mg/L)1.65 ± 3.932.03 ± 3.610.2160.620 (0.572 to 0.668)TC (mg/dL)199.95 ± 35.45205.11 ± 44.300.091WBC (103/µL)6019.63 ± 1735.576722.82 ± 1950.21 < 0.0001Hemoglobin (g/dL)14.23 ± 1.5015.34 ± 1.50 < 0.00010.682 (0.635 to 0.729)Insulin (µIU/mL)4.41 ± 3.027.76 ± 6.46 < 0.00010.717 (0.672 to 0.761)Vitamin D (ng/mL)18.99 ± 8.8919.27 ± 7.860.688Fatty liver index23.1 ± 20.7548.63 ± 25.5 < 0.00010.776 (0.737 to 0.816)Data are expressed as number (percentage) or mean ± standard deviation.

Source: General characteristics of patient with and those without MAFLD. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Medical records of men and women aged ≥ 19 years who underwent abdominal computed tomography (CT) examination at our facility between March 2012 and October 2019 were retrospectively reviewed.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease

Study design awaiting verification · Diabetology & Metabolic Syndrome · 2022

Original publication title

Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease

A Lum Han

© The Author(s) 2022

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our study verified the accuracy of FLI for predicting MAFLD using CT. The FLI can be used as a simple and cost-effective tool for screening MAFLD in clinical settings.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new nomenclature for nonalcoholic fatty liver. Along with obesity, fatty liver associated with metabolic dysfunction is increasing and has become a serious socioeconomic problem. Non-invasive testing for the confirmation of MAFLD, including the fatty liver index (FLI), can be used as an alternative method for diagnosing steatosis when imaging modalities are not available. To date, few studies have examined the effectiveness and validity of FLI for diagnosing MAFLD. Therefore, this study analyzed the effectiveness and validity of FLI for diagnosing MAFLD.

Source: Aims

Abstract: What methods does the paper describe?

Medical records of men and women aged ≥ 19 years who underwent abdominal computed tomography (CT) examination at our facility between March 2012 and October 2019 were retrospectively reviewed. A comparative analysis between non-continuous variables was performed using the chi-squared test. The area under receiver operating characteristic (AUROC) curve was used to verify the effectiveness of FLI as a predictive index for MAFLD.

Source: Methods

Abstract: Results

Analysis of the association between MAFLD and abdominal CT revealed that the sensitivity and specificity of FLI for diagnosing MAFLD were 0.712 and 0.713, respectively. The AUROC of FLI for predicting MAFLD was 0.776.

Source: Results

Abstract: Conclusions

Our study verified the accuracy of FLI for predicting MAFLD using CT. The FLI can be used as a simple and cost-effective tool for screening MAFLD in clinical settings.

Source: Conclusions
Authors’ abstract

Aims

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new nomenclature for nonalcoholic fatty liver. Along with obesity, fatty liver associated with metabolic dysfunction is increasing and has become a serious socioeconomic problem. Non-invasive testing for the confirmation of MAFLD, including the fatty liver index (FLI), can be used as an alternative method for diagnosing steatosis when imaging modalities are not available. To date, few studies have examined the effectiveness and validity of FLI for diagnosing MAFLD. Therefore, this study analyzed the effectiveness and validity of FLI for diagnosing MAFLD.

Methods

Medical records of men and women aged ≥ 19 years who underwent abdominal computed tomography (CT) examination at our facility between March 2012 and October 2019 were retrospectively reviewed. A comparative analysis between non-continuous variables was performed using the chi-squared test. The area under receiver operating characteristic (AUROC) curve was used to verify the effectiveness of FLI as a predictive index for MAFLD.

Results

Analysis of the association between MAFLD and abdominal CT revealed that the sensitivity and specificity of FLI for diagnosing MAFLD were 0.712 and 0.713, respectively. The AUROC of FLI for predicting MAFLD was 0.776.

Conclusions

Our study verified the accuracy of FLI for predicting MAFLD using CT. The FLI can be used as a simple and cost-effective tool for screening MAFLD in clinical settings.

Publication and source details

Original title: Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease

A Lum Han

Diabetology & Metabolic Syndrome · 2022

© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Korean Society for the Study of Obesity.KSSO202104Han A Lum

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T09:49:02.937763+00:00

DOI: 10.1186/s13098-022-00811-2 · PMC8939216